Fifth Third Bancorp Has $813,000 Stock Holdings in Addus HomeCare Corporation $ADUS

Fifth Third Bancorp boosted its position in Addus HomeCare Corporation (NASDAQ:ADUS) by 5,612.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 8,683 shares of the company’s stock after buying an additional 8,531 shares during the quarter. Fifth Third Bancorp’s holdings in Addus HomeCare were worth $813,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund raised its holdings in Addus HomeCare by 2.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after purchasing an additional 103 shares during the last quarter. ProShare Advisors LLC boosted its stake in shares of Addus HomeCare by 3.1% in the 4th quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock valued at $379,000 after purchasing an additional 105 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its stake in shares of Addus HomeCare by 0.6% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after purchasing an additional 106 shares during the last quarter. State of Wyoming grew its position in shares of Addus HomeCare by 25.7% during the 4th quarter. State of Wyoming now owns 523 shares of the company’s stock worth $56,000 after buying an additional 107 shares during the period. Finally, Private Trust Co. NA grew its position in shares of Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 788 shares of company stock valued at $73,506 over the last ninety days. 4.10% of the stock is currently owned by insiders.

Addus HomeCare Trading Up 1.0%

Shares of NASDAQ ADUS opened at $115.65 on Tuesday. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $124.43. The stock has a market cap of $2.16 billion, a price-to-earnings ratio of 21.38, a P/E/G ratio of 1.57 and a beta of 0.88. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08. The company’s fifty day moving average is $99.71 and its 200-day moving average is $101.23.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, May 4th. The company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. The business had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.42 EPS. Equities research analysts predict that Addus HomeCare Corporation will post 6.24 EPS for the current year.

Analyst Ratings Changes

ADUS has been the topic of several analyst reports. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a report on Friday. Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Barclays upped their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th. Finally, Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Monday, May 18th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $131.50.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.